Rwanda begins Marburg vaccinations to curb deadly outbreak
16 Articles
16 Articles
Rwanda begins Marburg vaccinations to curb deadly outbreak
KIGALI — Rwanda said Sunday it had begun administering vaccine doses against the Marburg virus to try to combat an outbreak of the Ebola-like disease in the east African country, where it has so far killed 12 people. "The vaccination is starting today immediately," Health Minister Sabin Nsanzimana said at a news conference in the capital Kigali. He said the vaccinations would focus on those "most at risk, most exposed health care workers worki…
U.S. Delivers Marburg Vaccine to Rwanda Amid Outbreak
U.S. Delivers Marburg Vaccine to Rwanda Amid Outbreak The United States has made a critical initial delivery of vaccine doses and therapeutic drugs to Rwanda, aiming to combat the outbreak of Marburg disease, as confirmed by Thierry Roels, U.S. CDC Country Director in Rwanda, to Reuters on Saturday.Working closely with international partners and Rwanda's Ministry of Health, the U.S. government is prepared to support clinical trials to evaluate …
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has provided its investigational Marburg vaccine to Rwanda to support the ongoing outbreak response. The initial shipment of approximately 700 vaccine doses will be used in a trial targeting frontline workers, including healthcare professionals who have been hardest hit by the …
US delivers Marburg vaccines to Rwanda after 11 die in outbreak – DNKL
KIGALI, Oct 5 (Reuters) – The United States government completed an initial shipment of vaccine doses and therapeutic drugs for Marburg disease to Rwanda on Oct. 4, Thierry Roels, the CDC’s U.S. country director for Rwanda, told Reuters on Saturday. The U.S. government is also working closely with international partners and the Rwandan Ministry of Health to begin clinical trials to evaluate investigational countermeasures, he said. Roels added t…
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium